Vista Current Coverage

All Healthcare/Biotech Articles

Pfizer Will Raise US Drug Prices in January

Pfizer (PFE)  is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. Pfizer has announced its plan to increase U.S. prices on 41 of its medicines this January. The company had pulled back its original...

CAR-T Pioneer Dr. Grupp Joins Paris Headquartered Cellectis (CLLS)’s CAB

Cellectis S.A. (Euronext Growth: ALCLS; Nasdaq: CLLS), founded in 1999 and headquartered in Paris, France, is a clinical stage biotechnological company, develops and sells immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer in France. The company operates...

Fate Therapeutics Reports Q3 2018 Financial Results & Highlights

Fate Therapeutics (Nasdaq: FATE), headquartered in San Diego, CA, is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. The Company is pioneering the development of off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC)...